Journal article
36 Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial
Authors
Mckelvie RS; Komajda M; Massie BM; McMurray JJ; Zile MR; Donovan M; Ptaszynska A; Carson P
Journal
European Journal of Heart Failure Supplements, Vol. 7, , pp. 2–2
Publisher
Oxford University Press (OUP)
Publication Date
June 1, 2008
DOI
10.1016/s1567-4215(08)60008-9
ISSN
1567-4215